WallStreetZenWallStreetZen

NASDAQ: OMER
Omeros Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for OMER

Based on 2 analysts offering 12 month price targets for Omeros Corp

Min Forecast
$9.00+106.9%
Avg Forecast
$22.50+417.24%
Max Forecast
$36.00+727.59%

Should I buy or sell OMER stock?

Based on 2 analysts offering ratings for Omeros Corp.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although OMER's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates OMER as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their OMER stock forecasts and price targets.

OMER stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-15
lockedlocked$00.00+00.00%2025-06-10

1 of 1

Forecast return on equity

Is OMER forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is OMER forecast to generate an efficient return on assets?

Company
-12.22%
Industry
46.72%
OMER is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OMER earnings per share forecast

What is OMER's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$1.94
Avg 2 year Forecast
-$1.32
Avg 3 year Forecast
-$1.19

OMER revenue forecast

What is OMER's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$3.0M
Avg 2 year Forecast
$12.4M
Avg 3 year Forecast
$76.6M

OMER vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
OMER$4.35$22.50+417.24%Strong Buy
DSGN$5.20N/AN/A
FHTX$5.25$11.67+122.23%Buy
ALT$3.39$17.25+408.85%Strong Buy
RNAC$11.25$39.33+249.63%Buy
View Top Biotech Stocks

Omeros Stock Forecast FAQ

Is Omeros Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: OMER) stock is to Strong Buy OMER stock.

Out of 2 analysts, 1 (50%) are recommending OMER as a Strong Buy, 1 (50%) are recommending OMER as a Buy, 0 (0%) are recommending OMER as a Hold, 0 (0%) are recommending OMER as a Sell, and 0 (0%) are recommending OMER as a Strong Sell.

If you're new to stock investing, here's how to buy Omeros stock.

What is OMER's earnings growth forecast for 2025-2027?

(NASDAQ: OMER) Omeros's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.36%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.32%.

Omeros's earnings in 2025 is -$122,474,000.On average, 2 Wall Street analysts forecast OMER's earnings for 2025 to be -$131,688,023, with the lowest OMER earnings forecast at -$148,361,701, and the highest OMER earnings forecast at -$115,014,346. On average, 2 Wall Street analysts forecast OMER's earnings for 2026 to be -$89,833,690, with the lowest OMER earnings forecast at -$113,653,229, and the highest OMER earnings forecast at -$66,014,151.

In 2027, OMER is forecast to generate -$80,986,433 in earnings, with the lowest earnings forecast at -$80,986,433 and the highest earnings forecast at -$80,986,433.

What is OMER's revenue growth forecast for 2025-2027?

(NASDAQ: OMER) Omeros's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 80.59%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.89%.

Omeros's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast OMER's revenue for 2025 to be $204,167,478, with the lowest OMER revenue forecast at $204,167,478, and the highest OMER revenue forecast at $204,167,478. On average, 1 Wall Street analysts forecast OMER's revenue for 2026 to be $843,892,242, with the lowest OMER revenue forecast at $843,892,242, and the highest OMER revenue forecast at $843,892,242.

In 2027, OMER is forecast to generate $5,213,076,272 in revenue, with the lowest revenue forecast at $5,213,076,272 and the highest revenue forecast at $5,213,076,272.

What is OMER's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: OMER) forecast ROA is -12.22%, which is lower than the forecast US Biotechnology industry average of 46.72%.

What is OMER's Price Target?

According to 2 Wall Street analysts that have issued a 1 year OMER price target, the average OMER price target is $22.50, with the highest OMER stock price forecast at $36.00 and the lowest OMER stock price forecast at $9.00.

On average, Wall Street analysts predict that Omeros's share price could reach $22.50 by Aug 15, 2026. The average Omeros stock price prediction forecasts a potential upside of 417.24% from the current OMER share price of $4.35.

What is OMER's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: OMER) Omeros's current Earnings Per Share (EPS) is -$2.12. On average, analysts forecast that OMER's EPS will be -$1.94 for 2025, with the lowest EPS forecast at -$2.18, and the highest EPS forecast at -$1.69. On average, analysts forecast that OMER's EPS will be -$1.32 for 2026, with the lowest EPS forecast at -$1.67, and the highest EPS forecast at -$0.97. In 2027, OMER's EPS is forecast to hit -$1.19 (min: -$1.19, max: -$1.19).

What is OMER's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: OMER) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.